Brain Radiation Therapy With or Without Cancer Drug Treatment

This study is comparing two approaches for patients newly diagnosed with cancer spread to the brain: one group receives standard cancer medications (like immunotherapy or targeted therapy) plus stereotactic radiosurgery, a highly focused radiation beam that targets tumors in the brain; the other group receives the standard cancer medications alone. Researchers want to know whether adding this specialized radiation treatment helps patients live longer and maintain a better quality of life.

When cancer spreads to the brain, doctors must decide quickly whether to use radiation therapy, standard cancer drugs, or both—and in what order. There is no clear consensus on the best approach, and the timing of treatment can significantly affect survival and how patients feel. This trial aims to provide clear evidence about the best strategy.